US2013203160A1PendingUtilityA1
Transgenomic Mitochondria, Transmitochondrial Cells and Organisms, and Methods of Making and Using
Individually held — no corporate assignee on recordPriority: Apr 15, 2004Filed: Apr 8, 2013Published: Aug 8, 2013
Est. expiryApr 15, 2024(expired)· nominal 20-yr term from priority
C12N 15/1027C12N 15/87C12N 15/8509C12N 2800/90C12N 1/16C12N 15/63C12N 15/81
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides transgenomic mitochondria, transmitochondrial cells and organisms, and the materials and methods for making such mitochondria, cells and organisms.
Claims
exact text as granted — not AI-modified1 . A method for making a transgenomic mitochondrion incorporating an exogenous mitochondrial genome comprising the steps of;
a) isolating a mitochondrial genome from a eukaryotic cell to yield an exogenous mitochondrial genome; b) modifying said isolated exogenous mitochondrial genome by insertion of one or more selectable markers, screening markers, replication sequences, or combinations thereof; c) introducing said modified isolated exogenous mitochondrial genome into a host mitochondrion from a second eukaryotic cell; d) removing said one or more selectable markers, replication sequences, or combinations thereof, from said modified isolated exogenous mitochondrial genome within said host mitochondrion; and e) isolating said transgenomic mitochondrion from said second eukaryotic cell.
2 . The method of claim 1 , wherein said host mitochondrion from said second eukaryotic cell is a yeast mitochondrion.
3 . The method of claim 2 , wherein said yeast mitochondrion is substantially free of endogenous mitochondrial DNA.
4 . The method of claim 1 , wherein said exogenous mitochondrial genome is an isolated animal mitochondrial genome.
5 . The method of claim 4 , wherein said isolated animal mitochondrial genome is modified prior to introduction into said isolated yeast mitochondrion.
6 . The method of claim 5 , wherein said isolated animal mitochondrial genome is modified by one or more selectable markers, screening markers, replication sequences, or combinations thereof, said selectable markers, screening markers, and replication sequences having a prokaryotic origin.
7 . The method of claim 5 , wherein said isolated animal mitochondrial genome is modified by one or more selectable markers, screening markers, replication sequences, or combinations thereof, said selectable markers, screening markers, and replication sequences having a eukaryotic origin.
8 . The method of claim 5 , wherein said isolated animal mitochondrial genome is modified by one or more selectable markers, screening markers, replication sequences, or combinations thereof, said selectable markers, screening markers, and replication sequences having a synthetic origin.
9 . The method of claim 5 , wherein said isolated animal mitochondrial genome constitutes at least 80% of naturally occurring said isolated animal mitochondrial genome.
10 . The method of claim 9 , wherein said isolated animal mitochondrial genome is introduced into said host yeast mitochondrion.
11 . The method of claim 10 , wherein said introduction of said isolated animal mitochondrial genome into said host yeast mitochondrion is by particle bombardment.
12 . A transgenomic mitochondrion comprising:
a mitochondrion having an outer membrane and an inner membrane; a matrix located inside said inner membrane; and an exogenous mitochondrial genome that is incorporated into and stably replicating within said matrix of said mitochondrion.
13 . The transgenomic mitochondrion of claim 12 , wherein said mitochondrion is an isolated yeast mitochondrion comprising an exogenous mitochondrial genome.
14 . The transgenomic mitochondrion of claim 12 , wherein said exogenous mitochondrial genome comprises an exogenous animal mitochondrial genome.
15 . The transgenomic mitochondrion of claim 14 , wherein said animal mitochondrial genome is selected from the group consisting of avian, mammalian, murine, bovine, porcine, or human mitochondrial genomes.
16 . The transgenomic mitochondrion of claim 13 , wherein said mitochondrion is a yeast mitochondrion comprising an animal mitochondrial genome.
17 . The transgenomic mitochondrion of claim 15 , wherein said animal mitochondrial genome is a mouse mitochondrial genome.
18 . The transgenomic mitochondrion of claim 15 , wherein said animal mitochondrial genome is a human mitochondrial genome.
19 . The transgenomic mitochondrion of claim 13 , wherein said isolated yeast mitochondrion is substantially free of endogenous yeast mitochondrial DNA.
20 . A transmitochondrial cell comprising:
a eukaryotic cell having a plasma membrane, cytoplasm, a nucleus; and a transgenomic mitochondrion incorporated into said cytoplasm of said eukaryotic cell, said transgenomic mitochondrion having a modified exogenous mitochondrial genome within said mitochondrion.
21 . The transmitochondrial cell of claim 20 , wherein said transgenomic mitochondrion is not endogenous to said eukaryotic cell.
22 . The transmitochondrial cell of claim 20 , wherein said modified exogenous mitochondrial genome is stably replicating within said transgenomic mitochondrion within said eukaryotic cell.
23 . The transmitochondrial cell of claim 21 , wherein said transgenomic mitochondrion is a yeast mitochondrion.
24 . The transmitochondrial cell of claim 22 , wherein said modified exogenous mitochondrial genome is an animal genome.Join the waitlist — get patent alerts
Track US2013203160A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.